Drug Topics November 13, 2024
Killian Meara

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.

The National Average Drug Acquisition Cost (NADAC) is a benchmark that provides drug prices to the pharmaceutical supply chain. The prices, which are determined by averaging prices from retail community pharmacies across the United States, are gathered from the monthly Retail Price Survey conducted by the Centers for Medicare and Medicaid Services (CMS). NADAC aims to provide more accurate drug prices for states who use it as a reference price when setting their reimbursement methodology.

At the National Community Pharmacists Association (NCPA) 2024 Annual Convention and Expo, held October 26 to 29 in Columbus, Ohio, Drug Topics sat down with AJ Loiacono, co-founder and CEO of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Interview / Q&A, Pharma, Pharma / Biotech, Supply Chain, Technology, Trends
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
DOJ Accuses Walgreens of Filling Millions of Illegitimate Prescriptions
DOJ sues Walgreens for allegedly filling millions of illegal prescriptions, including opioids
Beyond the stethoscope: the AI-powered revolution and personalized medicine will shape the next era of U.S. health care

Share This Article